Clinical trials
Observational Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 3 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 7 |
| The Hospital for Sick Children | 2 |
| University Health Network, Toronto | 2 |
| University of Alberta | 2 |
| Children's Hospital of Eastern Ontario | 1 |
| Halton, Jacqueline, M.D. | 1 |
| Kiadis Pharma | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Novartis Pharmaceuticals | 1 |
| University of British Columbia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 21 |
| Leukemia | 4 |
| Lymphoma | 3 |
| Osteosarcoma | 3 |
| Central Nervous System Neoplasms | 2 |
| Heart Defects, Congenital | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Neuroblastoma | 2 |
| Recurrence | 2 |
| Rhabdoid Tumor | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.